Does New York Medicaid Cover Rybelsus? NY Medicaid Guide 2026
For New York Medicaid enrollees trying to understand Rybelsus coverage, the answer is nuanced. NY Medicaid — managed by the New York NYDOH — applies unique criteria for Rybelsus (oral semaglutide) that aren’t the same as private plans.
NY Medicaid’s Formulary Status for Rybelsus
By federal mandate, Medicaid programs cannot exclude covered outpatient drugs from manufacturers participating in the Medicaid Drug Rebate Program. Novo Nordisk is enrolled in this program, meaning NY Medicaid is required to cover Rybelsus — though it may apply PA requirements and restrictions.
What this means:
- Rybelsus is included in NY Medicaid’s formulary but may be non-preferred
- Prior authorization is required regardless of MCO
- Copay: Little to no out-of-pocket cost (cost-sharing caps apply)
- Managed care organizations (MCOs) in New York might impose additional utilization management beyond the state PDL
Coverage for Diabetes vs. Weight Loss
For type 2 diabetes:
- Approval is more straightforward with a diagnosis of type 2 diabetes
- Required evidence: prescriber attestation and clinical records
- NY Medicaid MCOs authorize Rybelsus after step therapy requirements are satisfied
For weight loss/obesity:
- NY Medicaid has traditionally excluded anti-obesity medications
- However, CMS guidance has created pathways for state Medicaid programs to include anti-obesity medications via waivers
- Contact NY Medicaid or your MCO for the most current formulary status
How to Navigate Rybelsus Authorization Through NY Medicaid
- Coordinate with your prescriber submit a prior authorization — Include ICD-10 diagnosis codes, relevant lab results, and documentation of failed first-line therapies
- Know which managed care plan you’re on — New York Medicaid contracts with several MCOs, and each has their own formulary rules in addition to the state PDL
- Request a formulary exception if denied — Federal law require that enrollees can request non-formulary access with clinical justification
- Request a state fair hearing — You have the right to a state fair hearing after MCO denial of Rybelsus
What New York Enrollees Should Know
- No cost-sharing barrier: Unlike commercial insurance, financial barriers are lower — the challenge is navigating PA
- Dispensing: The majority of New York retail pharmacies participate in the Medicaid network, but specialty pharmacies may be required for Rybelsus
- Extended fills: Certain NY Medicaid MCOs offer mail-order dispensing to lower pharmacy visits